Wire · founder news, decoded · opportunities
FDA Clears AI Software for Subtype-Specific Sleep Apnea Classification
FDA has cleared HoneyNaps' SOMNUM V3.0, an AI software that automatically classifies sleep apnea subtypes (obstructive, central, mixed) from polysomnography data with 97%+ agreement, enabling more precise diagnostic scoring than manual analysis.
This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.
The Wire takeaway
If you're building sleep diagnostics or any clinical AI that competes with manual scoring, subtype-level classification just became the regulatory floor. HoneyNaps' 510(k) path—validation via algorithmic accuracy rather than clinical outcome trials—is now a proven route to market; build to that standard and you can follow the same clearance track.
Read the full story at sleepreviewmag.com →
Topics: Digital Health · fda-510k-clearance · ai-diagnostics · sleep-apnea · clinical-decision-support · digital-biomarkers